Icade: Invest Securities still a buyer, cuts TP

(CercleFinance.com) - Invest Securities has confirmed its "buy" rating on Icade shares, adjusting its target price from E46 to E43.
5, believing that the property group's shares are still attractive, despite an increased execution risk regarding stages 2 and 3 of the sale of Icade Santé.

While management concedes that the transaction's completion could take longer than anticipated (until 2026 in their opinion), they are not ruling out greater pressure on the sale price.

The ambitions and pace of deployment of the new strategic plan will depend very much on the level of asset write-downs ahead, the broker continues, pointing out that the cumulative dividends for 2023-26 represent 60% of the current share price.


Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.